Talk:Mazapertine

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Additional references[edit]

Potentially useful for anyone wishing to further expand the article:

Reitz AB. Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats. , J Pharm Biomed Anal , Volume 41 , Issue 2 , 2006 May 3
Reitz AB. Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolites. , Eur J Drug Metab Pharmacokinet , Volume 28 , Issue 4 , 2003 Oct-Dec
McKown LA. Recent advances in biotransformation of CNS and cardiovascular agents. , Curr Drug Metab , Volume 1 , Issue 3 , 2000 Nov
Reitz AB. Biotransformation of the antipsychotic agent, mazapertine, in dog--mass spectral characterization and identification of metabolites. , Xenobiotica , Volume 29 , Issue 5 , 1999 May
Buff D. Mazapertine and hyponatremia. , Biol Psychiatry , Volume 43 , Issue 6 , 1998 Mar 15
Bartoszyk GD. Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. , Life Sci , Volume 62 , Issue 7 , 1998